WHO-Geneva inspects Unit-2 facility of Mangalam Drugs & Organics

18 Feb 2017 Evaluate

Mangalam Drugs & Organics’ facility at Unit-2 has been inspected by WHO-Geneva and the authority has issued few procedural observations. The company shall respond to the same within stipulated time after the receipt of Audit Report. The company believes that the audit was successful.

Mangalam Drugs & Organics is a part of the MangalamGroup, manufactures chemicals such as API perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State. It has a multi-product manufacturing facility and a in-house Research and Development (R&D) Base.

Mangalam Drugs&Org. Share Price

23.84 -0.19 (-0.79%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×